牙髓间充质干细胞：对抗糖尿病的潜在有力武器。
Wharton's Jelly MSCs: Potential Weapon to Sharpen for Our Battle against DM.
机构信息
Department of Biochemistry, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.
Department of Biochemistry, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt; Department of Pharmacology and Biochemistry, Faculty of Pharmacy, The British University in Egypt (BUE), Cairo, Egypt; The Center for Drug Research and Development (CDRD), Faculty of Pharmacy, The British University in Egypt (BUE), Cairo, Egypt.
出版信息
Trends Endocrinol Metab. 2020 Apr;31(4):271-273. doi: 10.1016/j.tem.2020.01.001. Epub 2020 Feb 5.
Diabetes mellitus (DM) is a devastating metabolic disease. Stem cell therapy provides great hope to all diabetic patients. Umbilical cord (UC) Wharton's jelly mesenchymal stem cells (WJ-MSCs) specifically provides a potential cell therapy for DM. In this article, we discuss major advantages of WJ-MSCs and challenges facing their clinical utility in DM.
糖尿病（DM）是一种毁灭性的代谢性疾病。干细胞疗法为所有糖尿病患者带来了巨大的希望。脐带（UC）Wharton 胶间充质干细胞（WJ-MSCs）特别为 DM 提供了一种潜在的细胞治疗方法。在本文中，我们讨论了 WJ-MSCs 的主要优势及其在 DM 临床应用中面临的挑战。
Zotero 插件